TRDA
Entrada Therapeutics, Inc. · Healthcare
CFO Kory James Wentworth sold $195K of Entrada Therapeutics, Inc.
Sold$194,845
$15.59Price
12,500Shares
−20%Stake
What TRDA did after the filing
- The stock from Tue, Dec 26 close, $16.69
- −13.1%
- S&P 500, same days
- +4.8%
Measured over 30 trading days, to the Feb 8 close.
Traded Thu, Dec 21. Filed Tue, Dec 26, 11:35 AM ET, during the session. Returns use the Dec 26 close and the Feb 8 close. Not investment advice.